Dr. Parjeet Kaur is an experienced Endocrinologist and Diabetes Specialist practicing at Apollo Hospitals, Gurugram. She holds an MBBS, MD, and DM in Endocrinology, reflecting advanced training in the diagnosis and management of hormonal and metabolic disorders.
Dr. Kaur provides comprehensive endocrinology and diabetes care for adults, focusing on accurate diagnosis, personalized treatment plans, and long-term disease management. Her clinical practice includes the evaluation and treatment of diabetes, thyroid disorders, osteoporosis, obesity, pituitary disorders, adrenal diseases, and other endocrine conditions.
She follows an evidence-based approach and emphasizes patient education, preventive healthcare, and lifestyle modification as essential parts of managing chronic endocrine conditions. By helping patients understand their condition and treatment goals, she supports better day-to-day control and improved long-term health outcomes.
Dr. Kaur consults in English, Hindi, and Punjabi, allowing patients and families to communicate comfortably and clearly understand their diagnosis, treatment options, and follow-up care.
Patients seeking expert diabetes treatment, thyroid care, and hormone-related evaluation in Gurugram can consult Dr. Parjeet Kaur at Apollo Hospitals, Gurugram.
үргэлжлүүлэх
Асуултаа асууна уу
туршлага
Medanta – The Medicity Hospital, Gurugram April 2012 till September 2026 Services include both Outpatient and Inpatient Diabetes and Endocrinology care.
Clinical Observership 7th July 2019 – 14th July Mayo Clinic, Rochester, Minnesota, USA 2019
Senior Resident Department of Internal Medicine, Oct 2005 – June2008 All India Institute of Medical Sciences (AIIMS), New Delhi
Гишүүд
Дотоод шүүрлийн нийгэмлэг (АНУ)
American association of clinical Endocrinology (AACE)
A V Gandhi award (2011) For excellence in Endocrinology
MMS Ahuja Award (2011) For Best DM(Endocrinology) resident (AIIMS)
Silver Medal ISBMR (2018) For best research paper
Golden Aim Women Healthcare leader Award: Diabetology (2022) For excellence and leadership in healthcare
Судалгаа & Publications
01
Kaur P, Agarwala A, Makharia G, Bhatnagar S, Tandon N. Effect of gluten-free diet on metabolic control and anthropometric parameters in type 1 diabetes with subclinical celiac disease: A randomized controlled trial. Endocrine Practice. 2020;26(6):660-667.
02
Kaur P, Anjana RM, Tandon N, Singh MK, Mohan V, Mithal A. Increased prevalence of self-reported fractures in Asian Indians with diabetes: Results from the ICMRINDIAB population based cross-sectional study. Bone. 2020;135:115323.
03
Kaur P, Bansal R, Bhargava B, Mishra S, Gill H, Mithal A. Decreased handgrip strength in patients with type 2 diabetes: A cross-sectional study in a tertiary care hospital in north India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(1):325-329.
04
Kaur P, Gattani R, Singhal AA, Sarin D, Arora SK, Mithal A. Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: Data from single institution in India. Indian journal of endocrinology and metabolism. 2016;20(5):625.
05
Kaur P, Mahendru S, Mithal A. Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting. Indian journal of endocrinology and metabolism. 2016;20(5):595.
06
Kaur P, Mishra SK, Mithal A. Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency. Clinical endocrinology. 2015;83(3):327-331.
07
Kaur P, Mishra SK, Mithal A, Saxena M, Makkar A, Sharma P. Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India. Indian journal of endocrinology and metabolism. 2014;18(1):77.
08
Parjeet Kaur, Dwijraj Hegde, Priyanka Singh, Dheeraj Gautam, Deepak Sarin, Sanjay Bhadada, Ambrish Mithal, mRNA expression of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic and asymptomatic primary hyperparathyroidism, European Journal of Endocrinology, Volume 191, Issue 4, October 2024, Pages 457–462,
09
Gill HK, Kaur P, Mahendru S, Mithal A. Adverse effect profile and effectiveness of sodium glucose co-transporter 2 inhibitors (SGLT2i)-A prospective real-world setting study. Indian journal of endocrinology and metabolism. 2019;23(1):50.
10
Kaul B, Kaur P, Tripathi M, Khadgawat R, Ammini A, Agarwala S, Kaushal S, Dattagupta S. An unusual cause of reversible axonal neuropathy and hypertension in a 10-year-old girl. Journal of Clinical Neuroscience. 2012;19(8):1196-1197.
11
Kuchay MS, Kaur P, Mishra SK, Mithal A. The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study. Clinical Cases in Mineral and Bone Metabolism. 2017;14(2):131.
12
Mithal A, Kaur P. Osteoporosis in Asia: a call to action. Current osteoporosis reports. 2012;10(4):245-247.
13
Mithal A, Kaur P, Bansal B, Mishra SK, Wasir JS, Jevalikar G, Mahendru S. Usage of pioglitazone at Medanta, the Medicity. Indian journal of endocrinology and metabolism. 2014;18(1):111.
14
Mithal A, Kaur P, Singh VP, Sarin D, Rao DS. Asymptomatic primary hyperparathyroidism exists in North India: Retrospective data from 2 tertiary care centers. Endocrine Practice. 2015;21(6):581-585.
15
A Mithal, P Kaur. Dietary calcium intake and role of calcium in bone health in the indian population. Osteoporosis international 29, S113-S114.
16
M khandelwal, P kaur, A mithal, D sarin, S arora, A singhal. Bone disease in patients with primary hyperparathyroidism in india: prospective data from a single institution. Osteoporosis international 27, s736-s737
17
Ramkumar S, Kaur P, Joshi A, Ammini A. Sexual precocity with pituitary macroadenoma and bilateral multicystic ovaries-a case report. International Journal of Pediatric Endocrinology. 2013;2013(1):1-1.
18
Agarwal N, Mithal A, Kaur P, Dhingra V, Godbole M, Shukla M. Vitamin D and insulin resistance in postmenopausal Indian women. Indian journal of endocrinology and metabolism. 2014;18(1):89.
19
Beloyartseva M, Mithal A, Kaur P, Kalra S, Baruah MP, Mukhopadhyay S, Bantwal G, Bandgar TR. Widespread vitamin D deficiency among Indian health care professionals. Archives of osteoporosis. 2012;7(1):187-192.
20
Bhattacharya S, Goyal A, Kaur P, Singh R, Kalra S. Anticancer Drug-induced Thyroid Dysfunction. European Endocrinology. 2020;16(1):32.
21
Marwaha RK, Tandon N, Kaur P, Sastry A, Bhadra K, Narang A, Arora S, Mani K. Establishment of age-specified bone mineral density reference range for Indian females using dual-energy X-ray absorptiometry. Journal of Clinical Densitometry. 2012;15(2):241-249.
22
Kuchay MS, Mathew A, Kaur P, Mishra SK. Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism. Arch Endocrinol Metab. 2021 Oct 29;65(5):669-673. doi:10.20945/2359-3997000000408. Epub 2021 Sep 29. PMID: 34591412.
23
Mohammad Shafi Kuchay, José Ignacio Martínez-Montoro, Parjeet Kaur, José Carlos Fernández-García, Bruno Ramos-Molina. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Research Reviews,Volume 80, 2022,101696,ISSN 1568 1637 https://doi.org/10.1016/j.arr.2022.101696.
24
Agarwal N, Mithal A, Dhingra V, Kaur P, Godbole MM, Shukla M. Effect of two different doses of oral cholecalciferol supplementation on serum 25-hydroxy-vitamin D levels in healthy Indian postmenopausal women: A randomized controlled trial. Indian journal of endocrinology and metabolism. 2013;17(5):883.
25
Jevalikar G, Kohli C, Bansal B, Mishra SK, Wasir JS, Singh S, Ahuja JK, Kaur P, Farooqui KJ, Mithal A. Childhood and youth onset diabetes: A single centre experience. The Indian Journal of Pediatrics. 2016;83(8):792-798.
26
Kuchay MS, Krishan S, Mishra SK, Choudhary NS, Singh MK, Wasir JS, Kaur P, Gill HK, Bano T, Farooqui KJ. Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia. 2020;63(11):2434-2445.
27
Kuchay MS, Krishan S, Mishra SK, Farooqui KJ, Singh MK, Wasir JS, Bansal B, Kaur P, Jevalikar G, Gill HK. Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT Trial). Diabetes care. 2018;41(8):1801-1808.
28
Singhal AA, Baijal S, Sarin D, Arora S, Mithal A, Mishra S, Bansal B, Kaur P, Kuchay S, Wasir J. Parathyroid Carcinoma: Atypical Presentation, Diagnosed on Ultrasound: A Case Report. Ultrasound in Medicine and Biology. 2017;43:S179.
29
Singhal AA, Baijal S, Sarin D, Mithal A, Mishra S, Kuchay S, Bansal B, Kaur P, Arora S, Wasir J. To Establish the True Positive Percentage of Cases Where Ultrasound Detected Nodules in Sestamibi Negative Cases of Hyperparathyroidism. Retrospective Data from A Single Institution”. Ultrasound in Medicine and Biology. 2017;43:S114S115.
30
Kuchay MS, Choudhary NS, Gagneja S, Mathew A, Bano T, Kaur P, Bahadur B, Singh MK, Gill HK, Wasir JS, Sud R, Mishra SK. Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2021 Nov;36(11):3204-3211. doi: 10.1111/jgh.15595. Epub 2021 Jul 6. PMID: 34160089.
31
Kuchay MS, Choudhary NS, Mishra SK, Bano T, Gagneja S, Mathew A, Singh MK, Kaur P, Gill HK, Wasir JS, Sud R, Mithal A. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes. JGH Open. 2021 Jun 29;5(8):915-922. doi: 10.1002/jgh3.12606. PMID: 34386600; PMCID: PMC8341185.
32
Raghunathan V, Jevalikar G, Dhaliwal M, Singh D, Sethi SK, Kaur P, Singhi SC. Risk Factors for Cerebral Edema and Acute Kidney Injury in Children with Diabetic Ketoacidosis. Indian J Crit Care Med 2021; 25 (12):1446-1451.
33
Mohammad Shafi Kuchay,Anu Mathew,Mitali Parvathi, Parjeet Kaur,Jasjeet Singh Wasir,Harmandeep Kaur Gill,Rujul Jain,Sakshi Gagneja,Chhavi Kohli,Poonam Kumari,Manish Kumar Singh,Sunil K. Mishra. Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: a non-inferiority randomized trial. Diabetic Medicine 10 November 2022. https://doi.org/10.1111/dme.15002
34
Kuchay, Mohammad Shafi, Pushpender Khatana, Mitali Mishra, Parvathi Surendran, Parjeet Kaur, Jasjeet Singh Wasir, Harmandeep Kaur Gill et al. "Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial)." Acta Diabetologica (2023): 1-10
